Molecular effects of genistein on estrogen receptor mediated pathways.
about
A fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin bindingPrepubertal exposure to zearalenone or genistein reduces mammary tumorigenesisBRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cellsLow concentrations of the soy phytoestrogen genistein induce proteinase inhibitor 9 and block killing of breast cancer cells by immune cellsThe Anti-Cancer Effect of Polyphenols against Breast Cancer and Cancer Stem Cells: Molecular MechanismsEffects of soy phytoestrogens genistein and daidzein on breast cancer growthThe pros and cons of phytoestrogensGenistein effects on stromal cells determines epithelial proliferation in endometrial co-culturesMetabolic profiling reveals sphingosine-1-phosphate kinase 2 and lyase as key targets of (phyto-) estrogen action in the breast cancer cell line MCF-7 and not in MCF-12ASoy promotes juvenile granulosa cell tumor development in mice and in the human granulosa cell tumor-derived COV434 cell line.Steroid hormone activity of flavonoids and related compounds.Skin treatments and dermatological procedures to promote youthful skinIncreased expression of histone proteins during estrogen-mediated cell proliferation.Isoflavones are safe compounds for therapeutical applications - evaluation of in vitro data.Estrogen-mimicking isoflavone genistein prevents bone loss in a rat model of obstructive sleep apnea-hypopnea syndrome.Effects of isoflavones on breast density in pre- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trialsMolecular effects of soy phytoalexin glyceollins in human prostate cancer cells LNCaP.Genistein: does it prevent or promote breast cancer?The therapeutic potential of phytoestrogens.Impairment of ovarian function and associated health-related abnormalities are attributable to low social status in premenopausal monkeys and not mitigated by a high-isoflavone soy diet.Quercetin induces morphological and proliferative changes of rat's uteri under estrogen and progesterone influencesCardiovascular protective effects of 17beta-estradiol metabolites.Complementary/alternative therapies. Potential safety issues in cancer care.New opportunities in chemoprevention research.How significant are environmental estrogens to women?Genistein stimulates MCF-7 breast cancer cell growth by inducing acid ceramidase (ASAH1) gene expression.Species, interindividual, and tissue specificity in endocrine signaling.Chemotherapeutics and hormesis.Receptor tyrosine kinases and their hormonal regulation in uterine leiomyomaIn vitro & in vivo estrogenic activity of glycoside fractions of Solanum nigrum fruit.Soy isoflavones and cancer prevention.Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer.Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice.The effects of (-)-epicatechin on endothelial cells involve the G protein-coupled estrogen receptor (GPER).Multi-level engineering facilitates the production of phenylpropanoid compounds in tomato.Genistein treatment improves fracture resistance in obese diabetic mice.Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology studyCancer biology and hormesis: human tumor cell lines commonly display hormetic (biphasic) dose responses.Daidzein-estrogen interaction in the rat uterus and its effect on human breast cancer cell growth
P2860
Q21089729-0D66D002-EDC3-4AF0-AD81-D848C4173066Q24647300-C5FC4735-F0F8-42F3-8A1E-2A1A0CE66803Q24649679-57A26515-EDBE-44D4-B241-7DE7B3A77679Q24652441-73D0246C-AA22-4357-8205-A280FE73409BQ24656281-243BDE77-33E9-46CA-9F2D-6B03A7699F44Q28066752-7C16CDA9-CF38-47C4-8364-3029AC388F04Q28188936-B90D1CA9-25CE-4454-BFEA-FF68EC62A601Q28387746-0DEBD1B0-12F2-4C14-9374-4EA51AC58891Q28388428-19C922F5-F6B7-4007-8913-E033A419C8C5Q28484566-72858D0F-09B8-4425-9C0B-1A9A41EE5C95Q30370581-779E49A4-4905-40B5-ACA2-8675A1874F2DQ31440310-1D00842B-0125-4665-9A44-179CDA90A8D0Q33307750-DB55903F-F768-4F0B-B421-AA7458D09994Q33480517-AD184035-934A-443D-8D49-B3C48B3CB542Q33480555-108E146D-1305-41C5-86E5-FC18D03A1E2FQ33583043-F8254D29-EB20-4DFE-B616-807FF19E9EAFQ33590487-5B427EC4-2CDA-4BA9-909D-EA5704958290Q33667101-578AD00B-7CBF-42CD-9933-83D5721CE8D7Q34018154-CCBC8707-E783-4473-9ED9-D7804ED31F0BQ34075022-F7669A59-27A8-4DF2-BD07-5161DE9F29B8Q34341055-20DDFB2B-B60A-494E-9522-607B8C075059Q34371140-E87F3FBE-6E9A-4F07-B73E-659C59EFBEEFQ34377353-C9DBA52A-3027-4D49-8D81-C09DC09970D5Q34566172-537DB060-D074-4DAD-8055-FC3BDEBA3D84Q34569002-DFF167C1-D895-42DB-B074-AFD980D3DD77Q34573324-7EB4F502-E0A1-4DC7-A834-5032F42FA3FBQ35010927-0F56E15A-7DB1-483E-8D2E-AED84E2D64DDQ35032608-C06F94AC-8CD2-46F1-AEA9-16D870FF2C23Q35155701-59914287-13AE-47E2-9AFA-D75AA9389AF3Q35244896-3E1C7D47-C874-43B2-86DD-F8F0FECF0BA3Q35351957-29B8F1A3-E7DB-4B19-97DB-F23588027541Q35589203-828A7F6B-A519-4DCA-A79C-8467365E9B5AQ35702141-5ED66BAB-9F40-463B-B031-FD87FCFF6498Q35883554-844D3E62-B7B4-4475-AECE-642E4FD1E2A9Q36014772-216B8ED3-1BAD-46AA-9703-241291CFDD5BQ36265985-59D80B8D-CE60-4B7F-8434-F55CAEF00580Q36276089-793740ED-EBCB-4F95-90F7-621047F482D3Q36315926-448D4DEE-2827-4457-B93C-532D926C47E3Q36372255-2E14DC58-88F9-4338-B048-F623298E60F2Q36469463-55BF6353-5495-434A-B5B2-5DD3B196DC02
P2860
Molecular effects of genistein on estrogen receptor mediated pathways.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Molecular effects of genistein on estrogen receptor mediated pathways.
@en
type
label
Molecular effects of genistein on estrogen receptor mediated pathways.
@en
prefLabel
Molecular effects of genistein on estrogen receptor mediated pathways.
@en
P2093
P356
P1433
P1476
Molecular effects of genistein on estrogen receptor mediated pathways.
@en
P2093
N Sathyamoorthy
P304
P356
10.1093/CARCIN/17.2.271
P407
P577
1996-02-01T00:00:00Z